SNPMiner Trials (Home Page)
Report for Clinical Trial NCT01670396
Developed by Shray Alag, 2020.
SNP Clinical Trial Gene
The investigators hypothesized that genetic variants of G protein influence the development
of restenosis and clinical outcome of patients receiving drug-eluting stents (DES).
NCT01670396 Coronary Artery Disease
Primary Outcomes Measure: In-stent restenosis Time: 6-24months after stent implanting
Secondary Outcomes Measure: target lesion revascularization (TLR) Time: 6-24months after stent implanting
Measure: re-myocardial infarction Time: 6-24months after stent implating
Time Perspective: Retrospective
There is one SNP
and subsequent studies suggest that the T allele of C825T polymorphism is associated with
enhanced transmembrane signaling via Gi proteins. --- C825T ---